Response of neuroblastoma to retinoic acid in vitro and in vivo
- PMID: 2068138
Response of neuroblastoma to retinoic acid in vitro and in vivo
Similar articles
-
Multidrug-resistant human neuroblastoma cells are more differentiated than controls and retinoic acid further induces lineage-specific differentiation.Prog Clin Biol Res. 1991;366:181-91. Prog Clin Biol Res. 1991. PMID: 1676843 No abstract available.
-
Patterns of regulation of nuclear proto-oncogenes MYCN and MYB in retinoic acid treated neuroblastoma cells.Prog Clin Biol Res. 1991;366:151-6. Prog Clin Biol Res. 1991. PMID: 2068135 No abstract available.
-
Modulation of protein expression associated with chemically induced differentiation of neuroblastoma cells.Prog Clin Biol Res. 1991;366:157-63. Prog Clin Biol Res. 1991. PMID: 1712494 No abstract available.
-
Targeting oncogene expression in a childhood cancer.Hawaii Med J. 2003 Oct;62(10):224-5. Hawaii Med J. 2003. PMID: 14631595 Review. No abstract available.
-
Neuroblastoma: clinical perspectives, monoclonal antibodies, and retinoic acid.Ann Intern Med. 1982 Dec;97(6):873-84. doi: 10.7326/0003-4819-97-6-873. Ann Intern Med. 1982. PMID: 6756240 Review.
Cited by
-
Perspective on Similarities and Possible Overlaps of Congenital Disease Formation-Exemplified on a Case of Congenital Diaphragmatic Hernia and Neuroblastoma in a Neonate.Children (Basel). 2021 Feb 22;8(2):163. doi: 10.3390/children8020163. Children (Basel). 2021. PMID: 33671521 Free PMC article.
-
A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy.Br J Cancer. 2000 Nov;83(9):1124-7. doi: 10.1054/bjoc.2000.1425. Br J Cancer. 2000. PMID: 11027423 Free PMC article. Clinical Trial.
-
Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.Mol Carcinog. 2017 May;56(5):1472-1483. doi: 10.1002/mc.22607. Epub 2017 Jan 13. Mol Carcinog. 2017. PMID: 27996177 Free PMC article.
-
Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma.Front Pharmacol. 2022 Jun 2;13:908713. doi: 10.3389/fphar.2022.908713. eCollection 2022. Front Pharmacol. 2022. PMID: 35721107 Free PMC article. Review.
-
Antagonism of cytotoxic chemotherapy in neuroblastoma cell lines by 13-cis-retinoic acid is mediated by the antiapoptotic Bcl-2 family proteins.Mol Cancer Ther. 2010 Dec;9(12):3164-74. doi: 10.1158/1535-7163.MCT-10-0078. Mol Cancer Ther. 2010. PMID: 21159604 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical